whitepaper

Whitepaper: Neuroinflammation study

Posted: 15 July 2020 | | No comments yet

Neuroinflammation study by combining human iPSC-derived astrocytes and HTRF.

Activated astrocytes that release pro-inflammatory factors have been reported in neurodegenerative diseases. Monitoring neuroinflammation is important for further development of therapeutic treatments. Here we describe how hiPSC-derived astrocytes in combination with HTRF cellular assays offer a robust and physiologically relevant solution to study neuroinflammation pathways.











To read this whitepaper in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsor: Ncardia

Related organisations

Send this to a friend